Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

被引：0
|
作者：
Hamfjord, J. [1 ]
Guren, T. [1 ]
Dajani, O. [1 ]
Glimelius, B. [2 ]
Sorbye, H. [3 ]
Pfeiffer, P. [4 ]
Christoffersen, T. [5 ]
Lingjaerde, O. [5 ]
Tveit, K. [1 ]
Kure, E. [1 ]
Pallisgaard, N. [6 ,7 ]
Spindler, K.
机构：
[1] Oslo Univ Hosp, Oslo, Norway
[2] Uppsala Univ, Uppsala, Sweden
[3] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway
[4] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[5] Univ Oslo, Oslo, Norway
[6] Zealand Hosp, Roskilde, Denmark
[7] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O - 026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
    Hamfjord, J.
    Guren, T. K.
    Dajani, O.
    Johansen, J. S.
    Glimelius, B.
    Sorbye, H.
    Pfeiffe, P.
    Lingjaerde, O. C.
    Tveit, K. M.
    Kure, E. H.
    Pallisgaard, N.
    Spindler, K-L G.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1088 - 1095
  • [2] Identification of an immunological prognostic factor for metastatic colorectal cancer patients treated with first-line oxaliplatin-based chemotherapy
    Tada, K.
    Shoji, H.
    Kitano, S.
    Nishimura, T.
    Shimada, Y.
    Nagashima, K.
    Ito, A.
    Honma, Y.
    Iwasa, S.
    Okita, N.
    Takashima, A.
    Kato, K.
    Yamada, Y.
    Katayama, N.
    Boku, N.
    Heike, Y.
    Hamaguchi, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S80 - S80
  • [3] Handy prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer
    Chibaudel, B.
    Tournigand, C.
    Bonnetain, F.
    Andre, T.
    Lledo, G.
    Maindrault-Goebel, F.
    Larsen, A. K.
    Louvet, C.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    Yamamoto, Seiji
    Fujii, Hironori
    Murayama, Kotaro
    Iihara, Hirotoshi
    Watanabe, Daichi
    Yamada, Yunami
    Kobayashi, Ryo
    Kiyama, Shigeru
    Makiyama, Akitaka
    Urano, Kimihiko
    Matsuhashi, Nobuhisa
    Matsuura, Katsuhiko
    Suzuki, Akio
    ANTICANCER RESEARCH, 2023, 43 (11) : 5099 - 5105
  • [5] Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
    Chibaudel, Benoist
    Bonnetain, Franck
    Tournigand, Christophe
    Bengrine-Lefevre, Leila
    Teixeira, Luis
    Artru, Pascal
    Desrame, Jerome
    Larsen, Annette K.
    Andre, Thierry
    Louvet, Christophe
    de Gramont, Aimery
    ONCOLOGIST, 2011, 16 (09): : 1228 - 1238
  • [6] Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
    Gerger, Armin
    El-Khoueiry, Anthony
    Zhang, Wu
    Yang, Dongyun
    Singh, Harpreet
    Bohanes, Pierre
    Ning, Yan
    Winder, Thomas
    LaBonte, Melissa J.
    Wilson, Peter M.
    Benhaim, Leonor
    Paez, David
    El-Khoueiry, Rita
    Absenger, Gudrun
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5783 - 5792
  • [7] Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy
    Gerger, A.
    Zhang, W.
    Yang, D.
    Bohanes, P. O.
    Ning, Y.
    Winder, T.
    Labonte, M. J.
    Wilson, P. M.
    Benhaim, L.
    El-Khoueiry, R.
    Absenger, G.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    Baba, H.
    Watanabe, M.
    Okabe, H.
    Miyamoto, Y.
    Sakamoto, Y.
    Baba, Y.
    Iwatsuki, M.
    Chikamoto, A.
    Beppu, T.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 1950 - 1955
  • [9] Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
    H Baba
    M Watanabe
    H Okabe
    Y Miyamoto
    Y Sakamoto
    Y Baba
    M Iwatsuki
    A Chikamoto
    T Beppu
    British Journal of Cancer, 2012, 107 : 1950 - 1955
  • [10] Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
    Saltz, Leonard B.
    Clarke, Stephen
    Diaz-Rubio, Eduardo
    Scheithauer, Werner
    Figer, Arie
    Wong, Ralph
    Koski, Sheryl
    Lichinitser, Mikhail
    Yang, Tsai-Shen
    Rivera, Fernando
    Couture, Felix
    Sirzen, Florin
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2013 - 2019
12345